Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases

Cancers
Domenico Galetta, Lourdes Cortes-Dericks

Abstract

Despite tremendous efforts to improve the treatment of lung cancer, prognosis still remains poor; hence, the search for efficacious therapeutic option remains a prime concern in lung cancer research. Cell cycle regulation including mitosis has emerged as an important target for cancer management. Novel pharmacological agents blocking the activities of regulatory molecules that control the functional aspects of mitosis such as Aurora kinases are now being investigated. The Aurora kinases, Aurora-A (AURKA), and Aurora B (AURKB) are overexpressed in many tumor entities such as lung cancer that correlate with poor survival, whereby their inhibition, in most cases, enhances the efficacy of chemo-and radiotherapies, indicating their implication in cancer therapy. The current knowledge on Aurora kinase inhibitors has increasingly shown high potential in ensuing targeted therapies in lung malignancies. In this review, we will briefly describe the biology of Aurora kinases, highlight their oncogenic roles in the pre-clinical and clinical studies in lung cancer and, finally, address the challenges and potentials of Aurora kinases to improve the therapy of this malignancy.

References

Apr 18, 2003·Current Biology : CB·Patrick A EyersJames L Maller
May 10, 2003·Cell Research·Yu Wen KeXue Biao Yao
Nov 20, 2003·Nature Reviews. Molecular Cell Biology·Mar Carmena, William C Earnshaw
Dec 24, 2004·International Journal of Clinical Oncology·Yuichiro Ohe
Oct 17, 2006·Molecular Cancer Therapeutics·Steven L WarnerHaiyong Han
Nov 23, 2006·Biochemical and Biophysical Research Communications·Chongbo SunSpiros Linardopoulos
Nov 24, 2006·Molecular Cancer Therapeutics·Barbara VischioniGiuseppe Giaccone
Mar 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Kwang Woon KimBo Lu
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert W WilkinsonStephen Green
Jul 2, 2009·Nature Reviews. Drug Discovery·Silvia Lapenna, Antonio Giordano
Jul 18, 2009·Journal of Cancer Research and Clinical Oncology·John McLaughlinYasumichi Hitoshi
Feb 4, 2010·Molecular Cancer Therapeutics·Altaf A DarWael El-Rifai
Apr 8, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Stefania CrispiAlessandra Verdina
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Anat BiranYoel Kloog
Sep 25, 2010·Biochimica Et Biophysica Acta·Hiroshi Katayama, Subrata Sen
Jan 11, 2011·Biochemical and Biophysical Research Communications·Chun Chi WuShih-Lan Hsu
May 14, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Chang-Tze Ricky YuShih-Lan Hsu
Jul 2, 2011·Journal of Translational Medicine·Marco Lo IaconoGiorgio V Scagliotti
Oct 22, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H-T ArkenauI Judson
Mar 3, 2012·International Journal of Radiation Oncology, Biology, Physics·Ali SakWilfried E E Eberhardt
Jan 15, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Masafumi TakeshitaKatsuo Sueishi
May 20, 2015·The Journal of Biological Chemistry·Si LiChuanmao Zhang
Sep 9, 2015·Frontiers in Cell and Developmental Biology·Suzanne M Quartuccio, Karen Schindler
Jan 19, 2016·Frontiers in Oncology·Antonino B D'AssoroEvanthia Galanis
Feb 5, 2016·Molecular Cancer·Edmilson Ozorio Dos SantosDaniela Sanchez Bassères
Jul 15, 2016·Translational Lung Cancer Research·Cecilia Zappa, Shaker A Mousa
Aug 31, 2016·Lancet·Fred R HirschLuis Paz-Ares
Oct 6, 2016·Cancer Medicine·Zhu XingyuSong Yangrong
Dec 3, 2016·European Respiratory Review : an Official Journal of the European Respiratory Society·Anna C BibbyIoannis Psallidas
Jan 18, 2017·British Journal of Cancer·Ahmed Sk Al-KhafajiTriantafillos Liloglou
Feb 2, 2017·Oncotarget·Anqun TangJunnian Zheng

❮ Previous
Next ❯

Citations

Apr 9, 2021·Frontiers in Molecular Biosciences·Markus GlaßStefan Hüttelmaier
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Naheed Arfin Borah, Mamatha M Reddy
May 29, 2021·Journal of Cancer Research and Clinical Oncology·Azaj AhmedMd Imtaiyaz Hassan

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
biopsies
xenografts
antisense oligonucleotides
xenograft

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Anti-cancer Drugs
Warren LokMuhammad Wasif Saif
Current Biology : CB
Xin Zhang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Richard D CarvajalGary K Schwartz
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Madhu KollareddyMarian Hajduch
© 2021 Meta ULC. All rights reserved